KCA
AMED

KKR Credit Advisors’s Amedisys AMED Stock Holding History

KKR Credit Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$50.2M Buy
2,915,900
+2,155,597
+284% +$32M 6.31% 2
2013
Q2 		$8.84M Buy
+760,303
New +$8.71M 1.2% 36

Other funds holding AMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKR Credit Advisors's AMED Position: Q3 2013 in Review

KKR Credit Advisors increased its Amedisys (AMED) stake by 284% in Q3 2013, buying an estimated $32M and bringing the position to 2,915,900 shares worth $50.2M. The position accounts for 6.31% of the portfolio, ranked #2.

KKR Credit Advisors first reported a position in AMED in Q2 2013 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold AMED as of Q3 2013.

  • KKR Credit Advisors held 2,915,900 shares of Amedisys worth $50.2M as of Q3 2013.
  • KKR Credit Advisors bought 2,155,597 Amedisys shares in Q3 2013, an estimated $32M.
  • Amedisys made up 6.31% of KKR Credit Advisors's portfolio in Q3 2013, its #2 holding.
  • KKR Credit Advisors first reported a position in Amedisys in Q2 2013 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Amedisys as of Q3 2013.

Based on KKR Credit Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.